AIPHAS
AIPHAS is a Taipei-based healthcare SaaS company that builds aiKey, a cross-site medical data visualization platform aggregating patient records across Taiwanese hospitals for physicians and clinics operating within the NHI ecosystem.
- Company typePrivate
- Founded2019
- HeadquartersTaipei, Taiwan
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What AIPHAS does
AIPHAS (legal entity Aiphas. Co.) is a Taipei-based healthcare technology company that develops cross-site medical data visualization software for Taiwan's hospital ecosystem. Its core product, aiKey, aggregates patient information from multiple hospital information systems into a unified interface, enabling physicians to view medication history, lab results, medical images, and reports across hospital sites in under three clicks, with automated highlighting of critical events and NHI-aligned notifications to prevent repeat medications and duplicate tests. The platform is built on an API-first architecture using OCR for document processing, WebSocket for real-time data streaming, and MQTT for device communication, and is designed for workflow-isolated deployment that adds no IT staff workload.
The company monetizes through B2B SaaS subscriptions sold directly to hospitals, clinics, and pharmacies via a quote-based enterprise sales motion with annual billing and undisclosed pricing. Its customer base includes major Taiwanese medical centers and veterans hospitals such as National Taiwan University Hospital, Taipei Veterans General Hospital, Changhua Christian Hospital, Kaohsiung Veterans General Hospital, Tri-Service General Hospital, and Taipei Medical University, alongside smaller clinics such as ĒSEN Clinic. AIPHAS is co-led by Michael Huang (Co-Founder, Co-CEO, CTO) and Veronica Chung (Co-Founder, Co-CEO), holds ISO 27001 and ISO 27701 certifications, and operates exclusively in Taiwan with active investor outreach suggesting an ongoing capital raise. The company's earlier pandemic-response products, aiPass (April 2020) and aiDoor (August 2021), have been de-emphasized in favor of aiKey.
AIPHAS firmographics
Firmographics- Name
- AIPHAS
- Legal name
- Aiphas. Co.
- Website
- https://aiphas.tech
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AIPHAS is a Taipei-based healthcare SaaS company that builds aiKey, a cross-site medical data visualization platform aggregating patient records across Taiwanese hospitals for physicians and clinics operating within the NHI ecosystem.
- Ownership category
- akta.pro rank
AIPHAS industry classification
Industry- Product category
- Healthcare Data Analytics
- NAICS
- Software Publishers (513210), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN)
- akta.pro secondary industries
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)
Keywords
Where AIPHAS is headquartered
LocationHeadquarters
- HQ city
- Taipei
- HQ country
- Taiwan
- HQ region
- Asia
Offices2 records
Markets served
AIPHAS business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription (implied): B2B SaaS model selling aiKey platform to hospitals and healthcare providers. Pricing not publicly disclosed; quote-based enterprise sales model with demo booking and investor meeting inquiries indicating direct sales motion.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise hospital pricing (unspecified) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
AIPHAS product offering
Product offeringCore offering
AIPHAS develops and sells aiKey, a cross-site medical data visualization and prioritization platform that aggregates patient information from multiple hospital systems into a unified interface. The platform enables doctors to review medication history, lab results, medical images, and reports with automated critical event highlighting and NHI-aligned repeat treatment notifications. The 100% software service is designed for workflow-independent deployment within Taiwan's National Health Insurance ecosystem.
Product overview
AIPHAS offers aiKey as its primary product—a cross-site medical data visualization platform that aggregates patient information across multiple hospital sites. The platform enables doctors to view medication history, lab test results, medical images, and reports through a unified interface, highlighting critical events and providing notifications for repeat treatments. Previously, AIPHAS developed aiPass (April 2020), an automatic travel history checking system using OCR technology, and aiDoor (August 2021), a nurse station access control system adapted for crowd management during the COVID-19 pandemic.
Differentiator
Problem solved
Functional benefit
Brands
- aiKey: Cross-site medical data visualization and prioritization tool for doctors to manage patient conditions
- aiPass
- aiDoor
Products and services
- aiKey Cross-site medical data visualization and prioritization platform that aggregates patient medication history, lab results, medical images, and reports from multiple hospital sites into a unified interface for doctors, with critical event highlighting and NHI-aligned repeat treatment notifications.
- aiPass Previous product: automatic travel history checking system developed during the COVID-19 pandemic, using OCR technology and card holder verification to raise hospital checking efficiency by up to 10x.
- aiDoor Previous product: nurse station access control system adapted from aiPass for crowd control management in hospitals during the pandemic.
Quantifiable outcome
- Doctors locate information 10x faster with aiKey
- +5 more outcomes
Companies that use AIPHAS
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
AIPHAS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature5 records
AIPHAS partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
AIPHAS competitors and assessment
Company assessmentDirect peers
- Redox: Healthcare API integration platform that connects software applications to hospital EHRs and health systems, enabling cross-system data exchange. Directly comparable to AIPHAS's API-first integration approach for aggregating cross-site medical data.
- 1upHealth: FHIR-based healthcare data platform that aggregates patient records across multiple providers and EHR systems into a unified API. Comparable to aiKey in delivering a single, normalized view of cross-site medical data for clinicians and apps.
- Health Gorilla: Clinical data interoperability network that aggregates records from hospitals, labs, and imaging centers and surfaces them via API to providers. Comparable in cross-site clinical data aggregation and provider-facing workflows.
- Particle Health: Healthcare data API platform that retrieves and normalizes patient records from a national network of providers for use by payers and clinical apps. Comparable to AIPHAS in using APIs to deliver cross-organization patient data to clinicians.
- Bridge Connector (Tegria): Healthcare integration platform that connects disparate hospital systems and EHRs to enable data sharing across sites. Comparable to AIPHAS's cross-site aggregation and HIS integration approach.
Broad incumbents
- InterSystems: Established healthcare integration engine (HealthShare/IRIS for Health) used by hospitals and national health systems to exchange clinical data. Comparable as a broader, incumbent alternative to aiKey for cross-site medical data aggregation and interoperability.
- Veradigm (formerly Allscripts): Major EHR and healthcare data vendor with broad hospital footprint and native cross-site data exchange capabilities. Comparable as a large incumbent that could absorb aiKey-like functionality into its EHR suite.
- Epic Systems: Dominant US hospital EHR vendor with Care Everywhere interoperability network for cross-site record sharing. Comparable as the incumbent benchmark for cross-hospital clinical data exchange that AIPHAS competes against in concept.
Emerging players
- MphRx: Healthcare data aggregation and patient engagement platform that consolidates records from multiple systems into a single longitudinal patient record. Comparable to aiKey in cross-site medical data visualization for providers.
- Vim: Healthcare data integration layer that embeds referral, scheduling, and chart insights directly into provider EHR workflows. Comparable in building a workflow-integrated data layer on top of hospital EHR systems, similar to aiKey's workflow-independent overlay approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights6 records
Customer concentration
AIPHAS social profiles
Digital presenceAIPHAS compliance and trust
Trust signalCompliance2 records
AIPHAS financial estimates
Financial estimateRevenue estimate
Valuation estimate
AIPHAS leadership team
Management profileNumber of profiles
Profiles6 records
AIPHAS funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AIPHAS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AIPHAS
What does AIPHAS do?
AIPHAS develops and sells aiKey, a cross-site medical data visualization and prioritization platform that aggregates patient information from multiple hospital systems into a unified interface. The platform enables doctors to review medication history, lab results, medical images, and reports with automated critical event highlighting and NHI-aligned repeat treatment notifications. The 100% software service is designed for workflow-independent deployment within Taiwan's National Health Insurance ecosystem.
Is AIPHAS a public or private company?
AIPHAS is a private company. It is classified as venture growth investor backed and is currently operating.
When was AIPHAS founded?
AIPHAS was founded in 2019. It employs 1 to 10 people.
Where is AIPHAS based?
AIPHAS is headquartered in Taipei, Taiwan, in the Asia region.
How does AIPHAS make money?
One revenue line is on record: saaS Subscription (implied).
Who are AIPHAS's main competitors?
Direct peers on record are Redox, 1upHealth, Health Gorilla, Particle Health and Bridge Connector (Tegria). Broad incumbents are InterSystems, Veradigm (formerly Allscripts) and Epic Systems. Emerging players are MphRx and Vim.
Does AIPHAS have an API?
No public API is recorded for AIPHAS.
What industry is AIPHAS in?
AIPHAS's product category is Healthcare Data Analytics. Its primary akta.pro industry code is HLACAAAN, EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 513210 and its SIC code is 7372.